Rebalix
Logo iSharesiShares · sheet of 20 October 2026
ETF sheet · official issuer and register data

iShares UK Gilts 0-5yr UCITS ETF

IGL5 · IE000RCMNFR9 · GBP · domicile Ireland
Bonds · Government GBP · 0-5 years · Europe
Index tracked: FTSE Actuaries UK Conventional Gilts up to 5 Years Index (GBP)
TER
0.07%+ trans. 0.01%
Fund size
734 m EUR
Tracking difference
—not computable
🇮🇹 tax rate
12.62%white list 99.08%
Replication
Physical (optimised)
Income
Accumulating
Duration
2.14 yrsshort (≤3 years)
Launch 19 May 2023 · costs from the KID as of 2 Oct 2026 · 20 securities held · 2 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 7 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the FTSE UK Conventional Gilts – Up to 5 Years Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed and aims to invest so far as possible and practicable in the fixed income (FI) securities (such as bonds) that make up the Index and comply with its credit rating requirements. If the credit ratings of the FI securities are…

Performance since series start (in euro) — base 100

19 May 2023 → 16 Oct 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20242025202611799117
High 117 (16 Oct 2026) · low 99 (29 Jun 2023) · last 117. Past performance is not indicative of future results.

Returns in euro

1 year+5.3%
3 years+15.3%
5 yearsseries too young
10 yearsseries too young
Since series start+16.5%

Risk · 1 / 3 / 5 years

Volatility (ann.)2.34%2.21%—
Max drawdown−1.94%−1.94%—
Sharpe-0.120.35—
Sortino-0.170.50—
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IGL5 · IE000RCMNFR91
RebalixIGL5 · IE000RCMNFR9 · sheet of 20 October 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+5.17%+5.14%+0.04%
2024+2.55%+2.54%+0.01%

Fixed income — as declared by the issuer

Issuer page · 15 Oct 2026 · investment-grade share (BBB−/Baa3 and above): 100.0%
Rating breakdown (% of fund)
AA100.0%Cash and derivatives0.1%
Maturity breakdown (% of fund)
0–1 years20.2%1–2 years22.0%2–3 years23.6%3–5 years34.1%Cash and derivatives0.1%

Holdings

Portfolio as declared by the issuer · 30 Sept 2026 · 20 securities · top-10 weight = 58.1%
Countries (% of fund)
United Kingdom100.0%
Sectors (% of fund)
Treasury100.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
IGL5 · London Stock Exchange
BQ60 · Xetra (Deutsche Börse)
+ 2 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/uk/literature/kiid/ucits_kiid-ishares-uk-gilts-0-5yr…
Factsheet · www.blackrock.com/uk/literature/fact-sheet/igl5-ishares-uk-gilts-0-5yr…
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares…
The live sheet, always up to date
rebalix.com/en/etf/IE000RCMNFR9
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IGL5 · IE000RCMNFR92